158 related articles for article (PubMed ID: 6780189)
21. DNA synthesis during hormone-dependent mammary tumor regression in rats.
Goya RG; Sosa YE; Gómez CJ
J Natl Cancer Inst; 1983 Aug; 71(2):331-4. PubMed ID: 6410111
[TBL] [Abstract][Full Text] [Related]
22. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Sugamata N; Koibuchi Y; Iino Y; Morishita Y
Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
[TBL] [Abstract][Full Text] [Related]
23. Proceedings: Specificity of steroid binding by the oestrogen receptor of rat mammary tumours induced by 7,12-dimethylbenz(a)anthracene.
Powell-Jones W; Davies P; Wilson DW; Griffiths K
J Endocrinol; 1976 Mar; 68(3):30P. PubMed ID: 176305
[No Abstract] [Full Text] [Related]
24. Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Cho-Chung YS; Redler BH; Lewallen RP
Cancer Res; 1978 Oct; 38(10):3405-9. PubMed ID: 210937
[No Abstract] [Full Text] [Related]
25. Alteration in gene expression at the onset of hormone-dependent mammary tumor regression.
Huang FL; Cho-Chung YS
Cancer Res; 1983 May; 43(5):2138-42. PubMed ID: 6403232
[TBL] [Abstract][Full Text] [Related]
26. Antiestrogen modulation of the growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats.
Tsai TL; Rutledge S; Katzenellenbogen BS
Cancer Res; 1979 Dec; 39(12):5043-50. PubMed ID: 227594
[No Abstract] [Full Text] [Related]
27. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
Freudenstein J; Dasenbrock C; Nisslein T
Cancer Res; 2002 Jun; 62(12):3448-52. PubMed ID: 12067987
[TBL] [Abstract][Full Text] [Related]
28. Biological characteristics and estrogen and progesterone receptors in mammary carcinoma induced in male Sprague-Dawley rats by a series of intragastric intubations of 7,12-dimethylbenz(a)anthracene.
Yoshida H; Yoshida A; Fukunishi R; Sato B; Okamoto S; Matsumoto K
Cancer Res; 1982 Jun; 42(6):2434-9. PubMed ID: 6804090
[TBL] [Abstract][Full Text] [Related]
29. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of human urinary extract on the growth of DMBA-induced mammary tumors in Holtzman rat.
Sarkar S; Shah PN; Bagli NP
Neoplasma; 1981; 28(4):457-61. PubMed ID: 6793880
[TBL] [Abstract][Full Text] [Related]
31. Changes in chromatin composition associated with hormone-dependent mammary tumor regression.
Goya RG; Sosa YE
Int J Cancer; 1983 Mar; 31(3):281-4. PubMed ID: 6402454
[TBL] [Abstract][Full Text] [Related]
32. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
33. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.
Asselin J; Melançon R; Moachon G; Bélanger A
Cancer Res; 1980 May; 40(5):1612-22. PubMed ID: 6768450
[No Abstract] [Full Text] [Related]
35. Effect of actinomycin D on estrogen-induced changes in enzymes and nucleic acids of R3230AC mammary tumors, uteri, and mammary glands.
Hilf R; Michel I; Silverstein G; Bell G
Cancer Res; 1965 Dec; 25(11):1854-9. PubMed ID: 5892767
[No Abstract] [Full Text] [Related]
36. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
37. Peroxidase content in cell subpopulations of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Brightwell J; Tseng MT
Cancer Res; 1982 Nov; 42(11):4562-6. PubMed ID: 6812949
[TBL] [Abstract][Full Text] [Related]
38. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
Cho-chung YS; Doud FJ
Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II.
Huynh H; Alpert L; Pollak M
Cancer Res; 1996 Aug; 56(16):3651-4. PubMed ID: 8706001
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats.
Kang JS; Jung NJ; Kim S; Kim DJ; Jang DD; Yang KH
Eksp Onkol; 2004 Mar; 26(1):31-5. PubMed ID: 15112577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
